Copyright
©The Author(s) 2024.
World J Clin Oncol. Mar 24, 2024; 15(3): 447-455
Published online Mar 24, 2024. doi: 10.5306/wjco.v15.i3.447
Published online Mar 24, 2024. doi: 10.5306/wjco.v15.i3.447
Ref. | Nation | Design | Number of patients (M/F) | Therapy | ||
Experimental group | Control group | Experimental group | Control group | |||
Li et al[14], 2011 | China | NG | 23/7 | 17/9 | TACE + stenting | TACE + stenting + I125 |
Wang et al[16], 2009 | China | Retrospective study | 12/0 | 9/1 | TACE + stenting | TACE + 3-DCRT |
Wu et al[17], 2012 | China | Retrospective study | 43/7 | 51/5 | TACE + stenting | TACE + stenting + I125 |
Xiang et al[9], 2017 | China | Prospective study | 9/6 | 8/7 | TACE + stenting | TACE |
Zhang et al[18], 2008 | China | Retrospective study | 28/1 | 15/1 | TACE + stenting | TACE + stenting + 3-DCRT |
Zhang et al[15], 2009 | China | Retrospective study | 28/1 | 15/1 | TACE + stenting | TACE + stenting + 3-DCRT |
Zhang et al[10], 2011 | China | Retrospective study | 23/7 | 22/8 | TACE + stenting | TACE |
Zhang et al[19], 2016 | China | Retrospective study | 83/12 | 178/16 | TACE + stenting | TACE + stenting + I125 |
- Citation: Sui WF, Li JY, Fu JH. Transarterial chemoembolization plus stent placement for hepatocellular carcinoma with main portal vein tumor thrombosis: A meta-analysis. World J Clin Oncol 2024; 15(3): 447-455
- URL: https://www.wjgnet.com/2218-4333/full/v15/i3/447.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i3.447